Curis
CRIS
#11067
Rank
S$5.75 M
Marketcap
S$0.61
Share price
-23.59%
Change (1 day)
-58.97%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2026 (TTM): -S$11 Million

According to Curis's latest financial reports the company's current earnings are S$4.31 Million. In 2025 the company made an earning of -S$6.97 Million, an increase over its 2024 earnings that were of -S$55.18 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$11 Million57.96%
2025 -S$6.97 Million-87.38%
2024 -S$55.18 Million-5.77%
2023 -S$58.56 Million-13.1%
2022 -S$67.39 Million27.52%
2021 -S$52.85 Million65.09%
2020 -S$32.01 Million-9.1%
2019 -S$35.21 Million-4.73%
2018 -S$36.96 Million-41.95%
2017 -S$63.66 Million-14.37%
2016 -S$74.35 Million3.55%
2015 -S$71.8 Million271.52%
2014 -S$19.33 Million76.64%
2013 -S$10.94 Million
2011 -S$9.3 Million27.76%
2010 -S$7.28 Million-43.87%
2009 -S$12.96 Million-23.44%
2008 -S$16.93 Million56.66%
2007 -S$10.81 Million-16.71%
2006 -S$12.98 Million-36.92%
2005 -S$20.57 Million156.25%
2004 -S$8.03 Million-37.24%
2003 -S$12.79 Million-93.34%
2002 -S$0.2 Billion86.79%
2001 -S$0.11 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$8.98 B-82,581.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$14.61 B-134,238.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-S$79.83 Million 632.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
S$1.37 B-12,716.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-S$0.43 Billion 3,756.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-S$28.72 Million 163.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-S$0.26 Billion 2,203.50%๐Ÿ‡บ๐Ÿ‡ธ USA